Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

Richard Barker elected to Celgene’s board of directors

January 24, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing ABPI, Celgene, Richard Barker

Celgene, the biopharma firm specialising in cancer and inflammatory diseases, has elected Richard Barker to its board of directors. Dr …
Appointment

Alnylam cuts workforce by a third

January 23, 2012 Research and Development, Sales and Marketing Alnylam, Novartis, job cuts, rnai

Alnylam will cut 33% of its workforce this year as it looks to focus on developing its own products. The …
News

MPs to criticise NHS reforms

January 23, 2012 Sales and Marketing Clegg, Dorrell, NHS reform, health bill

Reform of the NHS is risking its financial stability and the care of the elderly, according to MPs. The concerns …
News

Merck pays $37m to settle Canadian Vioxx claims

January 23, 2012 Sales and Marketing Canada, Merck, Vioxx

Merck will pay a maximum of C$37 million to settle all claims against its painkiller Vioxx in Canada.  The settlement …
News

Payment changes of authority’s fees in France

January 20, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates, regulatory affairs

Changes are being made in the way fees are paid for regulatory submissions and procedures in France.  Fees are no …
News
Press release

Novartis’ Signifor recommended in Europe

January 20, 2012 Research and Development, Sales and Marketing CHMP, Cushing's disease, Novartis, Signifor

A European committee has recommended Novartis’ Signifor for the treatment of a rare, debilitating endocrine disorder. The European Committee for …
News

EMA to review safety of MS drug Gilenya

January 20, 2012 Research and Development, Sales and Marketing CHMP, EMA, Novartis, gilenya

The European Medicines Agency has begun a review into the safety of Novartis’ multiple sclerosis drug Gilenya. This follows concerns …
News

British pharmacy to sell ‘smart pills’

January 20, 2012 Sales and Marketing Lloyds pharmacy, Proteus Biomedical, smart pill

Proteus Biomedical has teamed up with Lloydspharmacy to sell Helius, a smart pill that tells a patient when to take …
News

AZ and BMS diabetes drug needs more data

January 20, 2012 Research and Development, Sales and Marketing AstraZeneca, BMS, FDA approvals, diabetes

AstraZeneca and Bristol-Myers Squibb must supply more data on their diabetes treatment dapagliflozin, the FDA says.Currently being developed as monotherapy, …
News

Novartis starts late-stage biosimilar trials for Amgen drugs

January 19, 2012 Research and Development, Sales and Marketing Amgen, Neulasta, Neupogen, Novartis

Novartis has begun Phase III biosimilar trials to copycat two of Amgen’s neutropenia drugs. The studies, which are being undertaken …
News

Chief operating officer appointed to Clinigen’s services division

January 19, 2012 Business Services, Medical Communications, Research and Development, Sales and Marketing Clinigen, Shaun Chilton

Clinigen Group, a global specialty pharma services and products business, has appointed Shaun Chilton as its new chief operating officer …
Appointment

Takeda to cut 2,800 jobs

January 19, 2012 Business Services, Research and Development, Sales and Marketing Nycomed, Takeda, job cuts

Takeda has announced plans to significantly reduce its global headcount over the next four years following its merger with Nycomed. …
News

Astellas Pharma Europe appoints Mike Crooks to head up its UK operations

January 19, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas Pharma, Mike Crooks

Astellas Pharma Europe, the European subsidiary of Tokyo-based Astellas Pharma, has appointed Mike Crooks as its new UK general manager. …
Appointment

Nurses come out against Health Bill

January 19, 2012 Sales and Marketing NHS, RCN, health bill, reforms

The union representing nurses and midwives in the UK has formally come out against the government’s health reform Bill.  The …
News

Bayer’s colorectal cancer drug increases survival

January 19, 2012 Research and Development, Sales and Marketing Bayer, colectoral cancer, regorafenib

Bayer and Onyx’s colorectal cancer drug regorafenib increased overall survival for late-stage patients, according to new data. The Phase III …
News
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026